Postmarket surveillance of 3D-printed implants for sacroiliac joint fusion
Received 20 July 2018
Accepted for publication 14 August 2018
Published 28 September 2018 Volume 2018:11 Pages 337—343
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Scott Fraser
Daniel Cher,1 Kendrick Wroe,2 W Carlton Reckling,3 Scott Yerby4
1Clinical Affairs, SI-BONE, Inc., Santa Clara, CA, USA; 2Quality Assurance, SI-BONE, Inc., Santa Clara, CA, USA; 3Medical Affairs, SI-BONE, Inc., Santa Clara, CA, USA; 4Research and Development, SI-BONE, Inc., Santa Clara, CA, USA
Background: Government regulations require postmarket surveillance for cleared/approved medical devices. Trend analysis of newly marketed devices may help to confirm device-related safety or uncover other device or procedure-related problems.
Methods: Complaints related to the use of 3D-printed triangular titanium implants for sacroiliac joint (SIJ) fusion were compared with those of the prior machined version of the device manufactured with a titanium plasma spray (TPS) coating. Event rates were calculated either by dividing event counts by numbers of surgeries or, for late events, using Kaplan–Meier survival analysis.
Results: Three types of complaints with nontrial frequencies were identified. Issues in instruments occurred at a low and constant rate (1.3%). Using Kaplan–Meier analysis, pain-related complaints occurred at a low and similar rate in both groups (<0.5%). The 1-year cumulative probability of surgical revision was low in both the 3D and machined versions of the device (1.5% for machined and 1% for 3D printed, P=0.0408 for difference). No implant breakages or migrations were identified in either group, and overall rates were similar to a previously published report.
Conclusion: The 3D-printed version of triangular titanium implant was associated with complaint and adverse event rates similar to those for the prior machined version of the device.
Keywords: permanent implants, quality system, complaint analysis, adverse events, postmarket surveillance, sacroiliac joint fusion
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]